Filter Lenses for the Prevention of Migraine Attacks
- Sponsor
- Rune Skovgaard Rasmussen
- Study ID
- NCT06161129
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Glasses
- Headache
- Migraine
- Visual Impairment
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Lenses — DEVICEThe filter lenses will be worn by participants for one month all day.
Study Details
The purpose is to investigate whether the Blue Cut for Night filter is better at reducing migraine compared to the FL-41 filter or a filter blocking light below 500 nm. A control group will use clear lenses without filter. This is a controlled, randomized and double-blind trial.
Key Dates
- First listed
- Dec 7, 2023
- Start date
- Mar 1, 2026
- Status verified
- Dec 2024
- Primary completion
- Aug 31, 2028
- Completion
- Feb 1, 2029
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- No Intervention: ControlGroup of 50 participants (control) will receive glasses with clear lenses.
- Active Comparator: FL-41Group of 50 participants will receive a glasses with an FL-41 filter.
- Active Comparator: BlueCutGroup of 50 participants will receive glasses with a Blue Cut filter.
- Active Comparator: 500nmGroup of 50 participants will receive glasses with a below 500 nm filter
Primary Outcome Measure
Change of pain intensity during migraine attacks [ Time Frame: Measured at inclusion, 4 weeks after inclusion, and 8 weeks after inclusion ]
Central Contacts
- Peter Smaakjær+45 58575769
- Rune S Rasmussen+45 28757500
Find similar trials
Nationwide
Related Studies
- Quality Improvement and Practice Based Research in Neurology Using the EMRPHASE4 · Enrolling By Invitation · Endeavor Health · Evanston, Illinois
- Pain Biomarker StudyPHASE1 · Enrolling By Invitation · The University of Texas Health Science Center, Houston · Houston, Texas
- Objectively Diagnose and Monitor Treatment of Light SensitivityRecruiting · Randy Kardon · Iowa City, Iowa
- Assessment of the Efficacy of Medrol Dose Pack for Acute Post-Concussive HeadachesRecruiting · Northwell Health · Manhasset, New York